- Home
- CYTK vs AHR Comparison
CYTK vs AHR Comparison
Compare CYTK & AHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTK
- AHR
- Stock Information
- Founded
- CYTK 1997
- AHR 2013
- Country
- CYTK United States
- AHR United States
- Employees
- CYTK N/A
- AHR N/A
- Industry
- CYTK Biotechnology: Pharmaceutical Preparations
- AHR
- Sector
- CYTK Health Care
- AHR
- Exchange
- CYTK Nasdaq
- AHR NYSE
- Market Cap
- CYTK 5.6B
- AHR 4.5B
- IPO Year
- CYTK 2004
- AHR 2024
- Fundamental
- Price
- CYTK $39.48
- AHR $30.60
- Analyst Decision
- CYTK Strong Buy
- AHR Strong Buy
- Analyst Count
- CYTK 17
- AHR 6
- Target Price
- CYTK $81.63
- AHR $33.33
- AVG Volume (30 Days)
- CYTK 2.6M
- AHR 2.2M
- Earning Date
- CYTK 05-07-2025
- AHR 05-08-2025
- Dividend Yield
- CYTK N/A
- AHR 3.30%
- EPS Growth
- CYTK N/A
- AHR N/A
- EPS
- CYTK N/A
- AHR N/A
- Revenue
- CYTK $18,474,000.00
- AHR $2,063,800,000.00
- Revenue This Year
- CYTK $55.84
- AHR $8.10
- Revenue Next Year
- CYTK $659.85
- AHR $6.36
- P/E Ratio
- CYTK N/A
- AHR N/A
- Revenue Growth
- CYTK 145.34
- AHR 11.11
- 52 Week Low
- CYTK $32.74
- AHR $12.92
- 52 Week High
- CYTK $68.76
- AHR $31.61
- Technical
- Relative Strength Index (RSI)
- CYTK 46.41
- AHR 57.99
- Support Level
- CYTK $37.79
- AHR $29.81
- Resistance Level
- CYTK $40.22
- AHR $29.29
- Average True Range (ATR)
- CYTK 3.16
- AHR 1.31
- MACD
- CYTK 0.25
- AHR 0.10
- Stochastic Oscillator
- CYTK 61.55
- AHR 80.33
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
About AHR AMERICAN HEALTHCARE REIT INC
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. It has four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of its revenue through Integrated Senior Health Campuses segment.